XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies. — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies. — Stella

Recruiting

Back to Pancreatic Adenocarcinoma Metastatic trials

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

China

Affiliated Hospital of Shandong First Medical University, Jinan, Shandong

Key details

Phase

Early testing / Safety & dosing

Sponsor

Evopoint Biosciences Inc.

Enrollment target

~240 participants

Started

July 2023

Primary completion

June 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov